The β-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureas

Microbiology

Volumn 153, Issue 7, 2007, Pages 2093-2103

  Stapleton, Paul D ^a   Shah, Saroj ^a   Ehlert, Kerstin ^b   Hara, Yukihiko ^c   Taylor, Peter W ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b BAYER PHARMA AG   (Germany)

^c Mitsui Norin Co Ltd ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; LIPOTEICHOIC ACID; LYSOSTAPHIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PEPTIDOGLYCAN; TEICHOIC ACID; TRITON X 100;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIUM ADHERENCE; CELL AGGREGATION; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CONTROLLED STUDY; CROSS LINKING; CYTOLYSIS; DRUG PROTEIN BINDING; ENZYME ACTIVITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; STAPHYLOCOCCUS AUREUS;

BETA-LACTAM RESISTANCE; CATECHIN; CELL WALL; PENICILLIN-BINDING PROTEINS; PEPTIDOGLYCAN; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 34447514359     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.2007/007807-0     Document Type: Article

References (44)

1. Appelbaum, P. C. (2006). The emergence of vancomycin-interinediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect 12 (Suppl. 1), 16-23.
2. Bera, A., Herbert, S., Jakob, A., Vollmer, W. & Götz, F. (2005). Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol 55, 778-787.
3. Blanco, A. R., Sudano-Roccaro, A., Spoto, G. C., Nostro, A. & Rusciano, D. (2005). Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates. Antimicrob Agents Chemother 49, 4339-4343.
4. Boyle-Vavra, S., Carey, R. B. & Daum, R. S. (2001). Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J Antimicrob Chemother 48, 617-625.
5. Caturia, N., Vera-Samper, E., Villallain, J., Mateo, C. R. & Micol, V. (2003). The relationship between the antioxidant and the antibacterial proper-ties of galloylated catechins and the structure of phospholipid model membranes. Free Radic Biol Med 34, 648-662.
6. Centers for Disease Control (2002). Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morbid Mortal Wkly Rep 51, 565-567.
7. Crisóstomo, M. I., Westh, H., Tomasz, A., Chung, M., Oliveira, D. C. & de Lencastre, H. (2001). The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci U S A 98, 9865-9870.
8. de Jonge, B. L. M. & Tomasz, A. (1993). Abnormal peptidoglycan produced in a methicillin-resistant strain of Staphylococcus aureus grown in the presence of methicillin: Functional role for penicillin-binding protein 2A in cell wall synthesis. Antimicrob Agents Chemother 37, 342-346.
9. de Jonge, B. L. M., de Lancastre, H. & Tomasz, T. (1991). Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain. J Bacteriol 173, 1105-1110.
10. Finan, J. E., Archer, G. L., Pucci, M. J. & Climo, M. W. (2001). Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45, 3070-3075.
11. Fournier, B. & Hooper, D. C. (2000). A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus. J Bacteriol 182, 3955-3964.
12. Hamilton-Miller, J. M. T. & Shah, S. (1999). Disorganization of cell division of methicillin-resistant Staphylococcus aureus by a component of tea (Camellia sinensis): A study by electron microscopy. FEMS Microbiol Lett 176, 463-469.
13. Hartman, B. J. & Tomasz, A. (1984). Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol 158, 513-516.
14. Hashimoto, T., Kumazawa, S., Nanjo, F., Hara, Y. & Nakayama, T. (1999). Interaction of tea catechins with lipid bilayers investigated with liposome systems. Biosci Biotechnol Biochem 63, 2252-2255.
15. Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. & Tenover, F. C. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40, 135-136.
16. Kajiya, K., Kumazawa, S. & Nakayama, T. (2001). Steric effects on interaction of tea catechins with lipid bilayers. Biosci Biotechnol Biochem 65, 2638-2643.
17. Kajiya, K., Kumazawa, S. & Nakayama, T. (2002). Effects of external factors on the interaction of tea catechins with lipid bilayers. Biosci Biotechnol Biochem 66, 2330-2335.
18. Koehl, J. L., Muthaiyan, A., Jayaswal, R. K., Ehlert, K., Labischinski, H. & Wilkinson, B. (2004). Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 48, 3749-3757.
19. Leloir, L. F. & Cardini, C. E. (1957). Characterization of phosphorus compound by acid lability. Methods Enzymol 3, 840-850.
20. Łeski, A. & Tomasz A. (2005). Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: Evidence for the cooperative functioning of PBP2, PBP4 and PBP2A. J Bacteriol 187, 1815-1824.
21. Miller, L. A., Ratnam, K & Payne, D. J. (2001). Beta-lactamase-inhibitor combinations in the 21st century: Current agents and new developments. Curr Opin Pharmacol 1, 451-458.
22. Ohta, K, Komatsuzawa, H., Sugai, M. & Suginaka, H. (2000). Triton X-100-induced lipoteichoic acid release is correlated with the methicillin resistance in Staphylococcus aureus. FEMS Microbiol Lett 182, 77-79.
23. Paschal, A., Vuong, C., Otto, M. & Götz, F. (2000). The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother 44, 2845-2847.
24. Pinho, M. G., de Lencastre, H. & Tomasz, A. (2000). Cloning, characterization, and inactivation of the gene pbpC, encoding penicillin-binding protein 3 of Staphylococcus aureus. J Bacteriol 182, 1074-1079.
25. Raychaudhuri, D. & Chatterjee, A. N. (1985). Use of resistant mutants to study the interaction of Triton X-100 with Staphylococcus aureus. J Bacteriol 164, 1337-1349.
26. Raynor, R. H., Scott D. F. & Best G. K. (1979). Oxacillin-induced lysis of Staphylococcus aureus. Antimicrob Agents Chemother 16, 134-140.
27. Roos, M., Pittenauer, E., Schmid, E., Beyer, M., Reinike, B., Allmaier, G. & Labischinski, H. (1998). Improved high-performance liquid chromatographic separation of peptidoglycan isolated from various Staphylococcus aureus strains for mass spectrometric characterization. J Chromatogr B Biomed Sci Appl 705, 183-192.
28. Shiota, S., Shimizu, M., Mizushima, T., Ito, H., Hatano, T., Yoshida, T. & Tsuchiya, T. (1999). Marked reduction in the minimum inhibitory concentration (MIC) of beta-lactams in methicillin-resistant Staphylococcus aureus produced by epicatechin gallate, an ingredient of green tea (Camellia sinensis). Biol Pharm Bull 22, 1388-1390.
29. Shirai, C., Sugal, M., Komatsuzawa, H., Ohta, K., Yamakido, M. & Suginaka, H. (1998). A triazine dye, cibacron blue F3GA, decreases oxacillin resistance levels in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 42, 1278-1280.
30. Sieradzki, K & Tomasz, A. (1996). A highly vancomycin-resistant laboratory mutant of Staphylococcus aureus. FEMS Microbiol Lett 142, 161-166.
31. Sieradzki, K. & Tomasz, A. (2003). Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol 185, 7103-7110.
32. Sieradzki, K., Pinho, M. G. & Tomasz, A. (1999). Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J Biol Chem 274, 18942-18946.
33. Stapleton, P. D. & Taylor, P. W. (2002). Methicillin resistance in Staphylococcus aureus: Mechanisms and modulation. Sci Prog 85, 57-72.
34. Stapleton, P. D., Shah, S., Anderson, J. C., Hara, Y., Hamilton-Miller, J. M. T. & Taylor, P. W. (2004). Modulation of beta-lactam resistance in Staphylococcus aureus by catechins and gallates. Int J Antimicrob Agents 23, 462-467.
35. Stapleton, P. D., Shah, S., Here, Y. & Taylor, P. W. (2006). Potentiation of catechin gallate-mediated sensitization of Staphylococcus aureus to oxacillin by nongalloylated catechins. Antimicrob Agents Chemother 50, 752-755.
36. Stranden, A. M., Ehlert, K, Labischinski, H. & Berger-Bächi, B. (1997). Cell wall monoglycine cross-bridges and methicillin, hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J Bacteriol 179, 9-16.
37. Sugai, M., Akiyama, T., Komatsuzawa, H., Miyake, Y. & Suginaka, H. (1990). Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis. J Bacteriol 172, 6494-6498.
38. Sugai, M., Komatsuzawa, H., Akiyama, T., Hong, Y.-M., Oshida, T., Miyake, Y., Yamaguchi, T. & Suginaka, H. (1995). Identification of endo-β-N-acetylglucosaminidase and N-acetylmuramyl-L -alanine amidase as duster-dispersing enzymes in Staphylococcus aureus. J Bacteriol 177, 1491-1496.
39. Suzuki, J., Komatsuzawa, H., Sugai, M., Ohta, K, Kozai, K., Nagasaka, N. & Suginaka, H. (1997). Effects of various types of triton X on the susceptibilities of methicillin-resistant staphylococci to oxacillin. FEMS Microbiol Lett 153, 327-331.
40. Taylor, P. W, Stapleton, P. D. & Paul Luzio, J. (2002). New ways to treat bacterial infections. Drug Discov Today 7, 1086-1091.
41. van Langevelde, P., van Dissel, J. T., Ravensbergen, E, Applemelk, B. J., Schrijver, I. A. & Groeneveld, P. H. P. (1998). Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: Quantitative measurements and biological reactivities. Antimicrob Agents Chemother 42, 3073-3078.
42. Wootton, M., Bennett, P. M., MacGowan, A. P. & Walsh, T. R. (2005). Reduced expression of the ad autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains. J Antimicrob Chemother 56, 944-947.
43. Yam, T. S., Hamilton-Miller, J. M. T. & Shah, S. (1998). The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2′ synthesis, and β-lactamase production in Staphylococcus aureus. J Antimicrob Chemother 42, 211-216.
44. Zhao, W.-H., Hu, Z.-Q, Okubo, S., Hara, Y. & Shimamura, T. (2001). Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45, 1737-1742.